Sort
10,766 grants matching “checkpoint inhibitor”
Novel multipronged Immunovirotherapy Approach for GBM Treatment
$354,017Evanthia Galanis · Mayo Clinic Rochester · R01 · FY2021 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$354,001Xin Lu · University Of Notre Dame · R01 · FY2022 · CA
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$353,987Xin Lu · University Of Notre Dame · R01 · FY2021 · CA
INTERACITONS OF HPV ONCOGENES WITH THE P53 PATHWAY
$353,950Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Regulation of PD-L1/PD-1 immune checkpoints by cis-interactions
$353,926Enfu Hui · University Of California, San Diego · R37 · FY2025 · CA
Delivery of cytokines for cancer immunotherapy using nanolayer-controlled trafficking of liposomal nanoparticles
$353,924Paula T Hammond · Massachusetts Institute Of Technology · R01 · FY2025 · CA
The replication checkpoint and genomic fidelity in skin
$353,781University Of Washington · R01 · FY2005 · AR
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$353,780Marco Colonna · Washington University · U01 · FY2012 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$353,780Marco Colonna · Washington University · U01 · FY2014 · AI
Inflammation and EGFR crosstalk in HNSCC Therapy
$353,763Andrean Llewela Burnett · University Of Iowa · R01 · FY2024 · DE
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
$353,666Jean Zhao · Brigham And Women'S Hospital · P50 · FY2021 · CA
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
$353,455Lanlan Shen · Baylor College Of Medicine · R01 · FY2023 · CA
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
$353,411David E Fisher · Massachusetts General Hospital · R01 · FY2021 · AR
Development of a Novel Approach to Immunotherapy.
$353,411Jane R Connor · Cadre Bioscience, Llc · R43 · FY2023 · CA
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$353,398Marco Colonna · Washington University · U01 · FY2015 · AI
Project 1: Active immunotherapy combined with checkpoint modulation for glioblastoma
$353,385Linda M Liau · University Of California Los Angeles · P50 · FY2020 · CA
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
$353,329Kavitha Yaddanapudi · University Of Louisville · R01 · FY2023 · CA
Structure/Function of Protein Tyrosine Phosphatases
$353,306Zhong-Yin Zhang · Purdue University · R01 · FY2025 · CA
Cell cycle regulation in response to plasma membrane stress in S. cerevisae
$353,250Amy E Ikui · Brooklyn College · SC1 · FY2019 · GM
Cell cycle regulation in response to plasma membrane stress in S. cerevisae
$353,250Amy E Ikui · Brooklyn College · SC1 · FY2020 · GM
Dynamic, live-cell monitoring of T-cell states against presented peptides
$353,204Jack Hu · Pumpkinseed Technologies Inc · R43 · FY2025 · CA
Kinetochore-Microtubule Interactions in Fission Yeast
$353,197J Richard McIntosh · University Of Colorado · R01 · FY2008 · GM
Mechanism of APE1 in DNA damage response
$353,137Shan Yan · University Of North Carolina Charlotte · R01 · FY2022 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$353,132Malay Haldar · University Of Pennsylvania · R37 · FY2024 · CA
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$353,107Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2024 · CA